Cited 3 times in
Comparison of Half-Time and Half-Irradiance Photodynamic Therapy in Nonresolving Central Serous Chorioretinopathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이승규 | - |
dc.contributor.author | 이지환 | - |
dc.date.accessioned | 2020-06-17T00:31:24Z | - |
dc.date.available | 2020-06-17T00:31:24Z | - |
dc.date.issued | 2020-03 | - |
dc.identifier.issn | 1080-7683 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/176006 | - |
dc.description.abstract | Purpose: To compare the efficacy of half-time and half-irradiance photodynamic therapy (PDT) in patients with nonresolving central serous chorioretinopathy (CSC) Methods: This retrospective study included 32 patients with nonresolving CSC, of whom 14 were treated with half-time PDT and 18 with half-irradiance PDT. Therapeutic outcomes, including central retinal thickness (CRT), subretinal fluid (SRF) height, subfoveal choroidal thickness (SFCT), thickness of the Haller layer (HL), thickness of the choriocapillaris/Sattler layer (SL), and best-corrected visual acuity (BCVA), were measured at baseline, and at 1 and 3 months after treatment. Results: CRT, SRF, and SFCT decreased significantly at 1 and 3 months after treatment in both groups. Thickness of the HL decreased significantly at 1 and 3 months, whereas thickness of the choriocapillaris/SL did not. BCVA demonstrated a significant improvement at 3 months in both groups. Changes in outcome parameters were not significantly different between the 2 groups. Conclusion: Both half-time and half-irradiance PDT were effective in SRF resolution and visual improvement, reducing choroidal thickness mainly on HL. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Association For Ocular Pharmacology And Therapeutics | - |
dc.relation.isPartOf | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Comparison of Half-Time and Half-Irradiance Photodynamic Therapy in Nonresolving Central Serous Chorioretinopathy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학교실) | - |
dc.contributor.googleauthor | Ji Hwan Lee | - |
dc.contributor.googleauthor | Sung Chul Lee | - |
dc.contributor.googleauthor | Christopher Seungkyu Lee | - |
dc.identifier.doi | 10.1089/jop.2019.0003 | - |
dc.contributor.localId | A02913 | - |
dc.contributor.localId | A03222 | - |
dc.relation.journalcode | J01654 | - |
dc.identifier.eissn | 1557-7732 | - |
dc.identifier.pmid | 31825265 | - |
dc.identifier.url | https://www.liebertpub.com/doi/abs/10.1089/jop.2019.0003 | - |
dc.subject.keyword | central serous chorioretinopathy | - |
dc.subject.keyword | choroid | - |
dc.subject.keyword | photochemotherapy | - |
dc.contributor.alternativeName | Lee, Christopher Seungkyu | - |
dc.contributor.affiliatedAuthor | 이승규 | - |
dc.contributor.affiliatedAuthor | 이지환 | - |
dc.citation.volume | 36 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 109 | - |
dc.citation.endPage | 115 | - |
dc.identifier.bibliographicCitation | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, Vol.36(2) : 109-115, 2020-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.